APOKYN (Tercica, Inc.)


Welcome to the PulseAid listing for the APOKYN drug offered from Tercica, Inc.. This Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Tercica, Inc.
NON-PROPRIETARY NAME: APOMORPHINE HYDROCHLORIDE
SUBSTANCE NAME: APOMORPHINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dopamine Agonists [MoA],Dopaminergic Agonist [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-07-02
END MARKETING DATE: 0000-00-00


APOKYN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAPOKYN from Tercica, Inc.
LABELER NAME: Tercica, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/3mL)
START MARKETING DATE: 2004-07-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15054-0211_750f74a5-be48-4849-be5c-ebcb6bae3dd8
PRODUCT NDC: 15054-0211
APPLICATION NUMBER: NDA021264

Other APOMORPHINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Remedy MakersAPOMORPHINUM MURIATICUM
Tercica, Inc.APOKYN
US WorldMeds, LLCAPOKYN